» Articles » PMID: 27058413

Gap Junction-mediated Transfer of MiR-145-5p from Microvascular Endothelial Cells to Colon Cancer Cells Inhibits Angiogenesis

Overview
Journal Oncotarget
Specialty Oncology
Date 2016 Apr 9
PMID 27058413
Citations 39
Authors
Affiliations
Soon will be listed here.
Abstract

Gap junctional communication between cancer cells and blood capillary cells is crucial to tumor growth and invasion. Gap junctions may transfer microRNAs (miRs) among cells. Here, we explore the impact of such a transfer in co-culture assays, using the antitumor miR-145 as an example. The SW480 colon carcinoma cells form functional gap junction composed of connexin-43 (Cx43) with human microvascular endothelial cells (HMEC). When HMEC are loaded with miR-145-5p mimics, the miR-145 level drastically increases in SW480. The functional inhibition of gap junctions, using either a gap channel blocker or siRNA targeting Cx43, prevents this increase. The transfer of miR-145 also occurs from SW480 to HMEC but not in non-contact co-cultures, excluding the involvement of soluble exosomes. The miR-145 transfer to SW480 up-regulates their Cx43 expression and inhibits their ability to promote angiogenesis. Our results indicate that the gap junctional communication can inhibit tumor growth by transferring miRs from one endothelial cell to neighboring tumor cells. This "bystander" effect could find application in cancer therapy.

Citing Articles

GJA1-20k, a Short Isoform of Connexin43, from Its Discovery to Its Potential Implication in Cancer Progression.

Fournier S, Clarhaut J, Cronier L, Monvoisin A Cells. 2025; 14(3).

PMID: 39936974 PMC: 11817742. DOI: 10.3390/cells14030180.


Horizontal mitochondrial transfer as a novel bioenergetic tool for mesenchymal stromal/stem cells: molecular mechanisms and therapeutic potential in a variety of diseases.

Iorio R, Petricca S, Mattei V, Delle Monache S J Transl Med. 2024; 22(1):491.

PMID: 38790026 PMC: 11127344. DOI: 10.1186/s12967-024-05047-4.


The direct transfer approach for transcellular drug delivery.

Wang Y, Shen Z, Xiang F, Wang H, Zhang P, Zhang Q Drug Deliv. 2023; 30(1):2288799.

PMID: 38037327 PMC: 10987047. DOI: 10.1080/10717544.2023.2288799.


MicroRNAs Derived from Extracellular Vesicles: Keys to Understanding SARS-CoV-2 Vaccination Response in Cancer Patients?.

Almeida B, Dias T, Teixeira A, Dias F, Medeiros R Cancers (Basel). 2023; 15(16).

PMID: 37627045 PMC: 10452664. DOI: 10.3390/cancers15164017.


The Multifaceted Role of Connexins in Tumor Microenvironment Initiation and Maintenance.

Kutova O, Pospelov A, Balalaeva I Biology (Basel). 2023; 12(2).

PMID: 36829482 PMC: 9953436. DOI: 10.3390/biology12020204.


References
1.
Sirnes S, Lind G, Bruun J, Fykerud T, Mesnil M, Lothe R . Connexins in colorectal cancer pathogenesis. Int J Cancer. 2014; 137(1):1-11. DOI: 10.1002/ijc.28911. View

2.
Carystinos G, Katabi M, Laird D, Galipeau J, Chan H, Alaoui-Jamali M . Cyclic-AMP induction of gap junctional intercellular communication increases bystander effect in suicide gene therapy. Clin Cancer Res. 1999; 5(1):61-8. View

3.
Visone R, Croce C . MiRNAs and cancer. Am J Pathol. 2009; 174(4):1131-8. PMC: 2671346. DOI: 10.2353/ajpath.2009.080794. View

4.
Zhang H, Pu J, Qi T, Qi M, Yang C, Li S . MicroRNA-145 inhibits the growth, invasion, metastasis and angiogenesis of neuroblastoma cells through targeting hypoxia-inducible factor 2 alpha. Oncogene. 2012; 33(3):387-97. DOI: 10.1038/onc.2012.574. View

5.
Matejuk A, Collet G, Nadim M, Grillon C, Kieda C . MicroRNAs and tumor vasculature normalization: impact on anti-tumor immune response. Arch Immunol Ther Exp (Warsz). 2013; 61(4):285-99. DOI: 10.1007/s00005-013-0231-4. View